Emerging brain connectivity network studies suggest that interactions between various distributed neuronal populations may be characterized by an organized complex topological structure. Many neuropsychiatric disorders are associated with altered topological patterns of brain connectivity. Therefore, a key inquiry of connectivity analysis is to detect group-level differentially expressed connectome patterns from the massive neuroimaging data. Recently, statistical methods have been developed to detect differentially expressed connectivity features at a subnetwork level, extending more commonly applied edge level analysis. However, the graph topological structures in these methods are limited to community/cliques which may not effectively uncover the underlying complex and disease-related brain circuits/subnetworks. Building on these previous subnetwork detection methods, a new statistical approach is developed to automatically identify the latent differentially expressed brain connectivity subnetworks with k-partite graph topological structures from large brain connectivity matrices. In addition, statistical inferential techniques are provided to test the detected topological structure. The new methods are evaluated via extensive simulation studies and then applied to resting state fMRI data (24 cases and 18 controls) for Parkinson's disease research. A differentially expressed connectivity network with the k-partite graph topological structure is detected which reveals underlying neural features distinguishing Parkinson's disease patients from healthy control subjects.Mass spectrometry (MS) plays an important role in seeking biomarkers for disease detection. High-quality quantitative data is needed for accurate analysis of metabolic perturbations in patients. This article describes recent developments in MS-based non-targeted metabolomics research with applications to the detection of several major common human diseases, focusing on study cohorts, MS platforms utilized, statistical analyses and discriminant metabolite identification. Potential disease biomarkers recently discovered for type 2 diabetes, cardiovascular disease, hepatocellular carcinoma, breast cancer and prostate cancer through metabolomics are summarized, and limitations are discussed.Understanding molecular, cellular, genetic and functional heterogeneity of tumors at the single-cell level has become a major challenge for cancer research. The microfluidic technique has emerged as an important tool that offers advantages in analyzing single-cells with the capability to integrate time-consuming and labour-intensive experimental procedures such as single-cell capture into a single microdevice at ease and in a high-throughput fashion. Single-cell manipulation and analysis can be implemented within a multi-functional microfluidic device for various applications in cancer research. Here, we present recent advances of microfluidic devices for single-cell analysis pertaining to cancer biology, diagnostics, and therapeutics. We first concisely introduce various microfluidic platforms used for single-cell analysis, followed with different microfluidic techniques for single-cell manipulation. Then, we highlight their various applications in cancer research, with an emphasis on cancer biology, diagnosis, and therapy. Current limitations and prospective trends of microfluidic single-cell analysis are discussed at the end.Ion mobility separations coupled to mass spectrometry (IM-MS) have received much attention for their ability to provide complementary structural information to solution-phase-based separations, as well as to aid in the identification of unknown compounds. While IM-MS is an increasingly powerful analytical technique, significant bottlenecks related to the resolution of measurements have kept it from becoming broadly applied for biological analyses. Presently, IM-MS-based measurements also remain limited in terms of their sensitivity as compared to state of the art MS-based approaches alone. Structures for Lossless Ion Manipulations (SLIM)-based IM separations provide a basis for overcoming these bottlenecks, addressing issues associated with resolution and sensitivity in the omics, and potentially opening the door to much broader application.There exists a moderate correlation between MRI-measured brain size and the general factor of IQ performance (g), but the question of whether the association reflects a theoretically important causal relationship or spurious confounding remains somewhat open. Previous small studies (n less then 100) looking for the persistence of this correlation within families failed to find a tendency for the sibling with the larger brain to obtain a higher test score. We studied the within-family relationship between brain volume and intelligence in the much larger sample provided by the Human Connectome Project (n = 1,022) and found a highly significant correlation (disattenuated ρ = 0.18, p less then .001). https://www.selleckchem.com/products/epz015666.html We replicated this result in the Minnesota Center for Twin and Family Research (n = 2,698), finding a highly significant within-family correlation between head circumference and intelligence (disattenuated ρ = 0.19, p less then .001). We also employed novel methods of causal inference relying on summary statistics from genome-wide association studies (GWAS) of head size (n ? 10,000) and measures of cognition (257,000 less then n less then 767,000). Using bivariate LD Score regression, we found a genetic correlation between intracranial volume (ICV) and years of education (EduYears) of 0.41 (p less then .001). Using the Latent Causal Variable method, we found a genetic causality proportion of 0.72 (p less then .001); thus the genetic correlation arises from an asymmetric pattern, extending to sub-significant loci, of genetic variants associated with ICV also being associated with EduYears but many genetic variants associated with EduYears not being associated with ICV. This is the pattern of genetic results expected from a causal effect of brain size on intelligence. These findings give reason to take up the hypothesis that the dramatic increase in brain volume over the course of human evolution has been the result of natural selection favoring general intelligence.